Cir-Q

Name: Cir-Q
Brand: Health Concerns

BrandHealth Concerns→Other Combinations Tablet or Pill 15 ingredients DSLD #22775

Net contents: 90 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2013-06-25

2 Ingredients (15)

IngredientGroupSafety

Proprietary BlendProprietary Blend—

BenzoinBenzoin—

LigusticumLigusticum—

SalviaSalvia (unspecified)—

Red PeonyPeony (unspecified)—

LinderaLindera (unspecified)—

FrankincenseBoswelliaGenerally Safe

CarthamusCarthamus (unspecified)—

Baked LicoriceLicorice —

SandalwoodSandalwood (unspecified)—

Acanthopanax cortexEleuthero—

Vegetable Gumvegetable gum (unspecified)—

Silicon DioxideSiliconGenerally Safe

Stearic AcidStearic Acid—

CelluloseCellulose—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

3 Safety cross-reference

Boswellia — Generally Safe

⚠ GI discomfort

⚠ May enhance anticoagulants

Silicon — Generally Safe

⚠ Very low toxicity

4 Label claims

• All Other

5 Data source

DSLD ID22775

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2013-06-25

6 More from Health Concerns

View Health Concerns Safety Scorecard → 25 products

AC-Q Tabs Siler Adrenosen Calm Spirit Clear Heat Colostroplex Colostroplex Recovery

7 Cite this page

Vancouver

Pkhakadze G. Cir-Q — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/products/cir-q-22775/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG